Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunostimulatory agents in combination with angiogenesis inhibitors

Immunostimulatory agents in combination with angiogenesis inhibitors

US Patent 11834483 · Granted Dec 5, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for subcutaneous administration of cancer immunotherapy2024
Compositions and methods for subcutaneous administration of cancer immunotherapy2024
Compositions and methods for subcutaneous administration of cancer immunotherapy2024
Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors2024
Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors2024
Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors2024
Compositions and methods for modulating IL-10 immunostimulatory and anti-inflamm2022
Compositions and methods for subcutaneous administration of cancer immunotherapy2022
Compositions and methods for subcutaneous administration of cancer immunotherapy2022
Compositions and methods for subcutaneous administration of cancer immunotherapy2022
Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors2022
Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors2022